Federal officials approved a new non-opioid painkiller developed by a Boston pharmaceutical company on Thursday, calling it a “first-in-class” treatment that avoids the addictive risks of opioid-based ...

Last week, the Food and Drug Administration approved Journavx, the first non-addictive opioid-like pain medication. Scientific discoveries at Yale were key to the development of the drug. Journavx, ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

Fatal overdoses in the US are falling - and Kayla's state of North Carolina is at the forefront of that trend.

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...

A specially produced compound from the cannabis plant has dramatically helped people suffering with long term back pain according to scientists in Germany.

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

Penn Medicine researchers have discovered that psilocybin, a natural compound found in some psychedelic mushrooms, can ...

Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than placebos ...